OBJECTIVE: Experimental and clinical studies have indicated a beneficial effect of retrograde lung preservation on post-transplant results. Accordingly, we conducted a non-randomized trial. METHODS: A total of 209 consecutive recipients transplanted with low-potassium dextrane (LPD)-preserved lungs were eligible for analysis. Antegrade lung preservation (AP) was performed in 173 patients and retrograde in situ perfusion (RP) in 36 patients using low-potassium dextrane solution in all cases. The prostacycline was added to preservation solution. RESULTS: The main donor, graft and recipient characteristics did not differ significantly between groups. There was a beneficial trend toward improved oxygenation indices in the RP cohort within the initial 48 post-transplant hours. The incidence of severe primary graft dysfunction was comparable up to 48 h post-transplant and was significantly increased in the RP cohort 72 h post-transplant (2.2% AP vs 14.8% RP, P = 0.016). Fatal bronchial dehiscences occurred more often in RP recipients (5.6% RP vs 0.6% AP, P = 0.067). The occurrence of bronchial stenoses revealed a slightly improved trend in the RP group (24.9% AP vs 13.9% RP, P = 0.218). Survival (P = 0.927) and bronchiolitis obliterans syndrome-free survival (P = 0.337) were comparable between groups. CONCLUSION: In our clinical survey, this analysis does not confirm the beneficial results of retrograde lung preservation alone, as was previously observed in experimental studies.
- Gohrbandt, B.; Warnecke, G.; Fischer, S.; Simon, A. R.; Gottlieb, J.; Niehaus, A.; Bothig, D.; Haverich, A.; Strueber, M.
Keywords
- Adult
- Cohort Studies
- Female
- Follow-Up Studies
- Graft Rejection
- Graft Survival
- Humans
- Kaplan-Meier Estimate
- Lung Transplantation/adverse effects/*methods/*mortality
- Male
- Middle Aged
- Multivariate Analysis
- Organ Preservation/*methods
- Organ Preservation Solutions/*pharmacology
- Proportional Hazards Models
- Retrospective Studies
- Risk Assessment
- Statistics, Nonparametric
- Survival Analysis
- Time Factors
- Tissue Donors
- Treatment Outcome
- Airway complication
- BOS-free survival
- Lung transplantation
- Primary graft dysfunction
- Retrograde lung preservation